A Case Report of Safe Coadministration of Amiodarone with Short‐Term Treatment Nirmatrelvir‐Ritonavir-Reference-Cited by-同舟云学术

A Case Report of Safe Coadministration of Amiodarone with Short‐Term Treatment Nirmatrelvir‐Ritonavir

Published:2022-12-21 Issue:4 Volume:113 Page:768-769
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin Pharma and Therapeutics

Author:

Sluijters Alice¹^ORCID,Lemaitre Florian²³⁴^ORCID,Belkhir Leïla¹²,Boland Lidvine⁵,Haufroid Vincent²⁵^ORCID,De Greef Julien¹²^ORCID

Affiliation:

1. Department of Internal Medicine and Infectious Diseases Cliniques Universitaires Saint‐Luc Brussels Belgium

2. Louvain Center for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique Université Catholique de Louvain Brussels Belgium

3. Pharmacology Department, Hôpital Pontchaillou, Université Rennes, Centre Hospitalier Universitaire de Rennes, Institut National de la Santé et de la Recherche Médicale, École des Hautes Études en Santé Publique Irset (Institut de Recherche en Santé, Environnement et Travail)‐UMR S 1085 Rennes France

4. Institut National de la Santé et de la Recherche Médicale Centre d'Investigation Clinique 1414 Rennes France

5. Department of Laboratory Medicine Cliniques Universitaires Saint‐Luc Brussels Belgium

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2805

Reference5 articles.

1. Recommendations for the Management of Drug–Drug Interactions Between the COVID ‐19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications

2. Prescribing Amiodarone

3. Population pharmacokinetics of long-term oral amiodarone therapy